2024

Bob Elfanbaum Joins NMS Capital’s Operating Executive Council to Assist with Future Investments in IT Services

New York, NY, July 1, 2024 – NMS Capital (“NMS”), announced today a new executive partnership with Bob Elfanbaum to pursue platform investments in the IT services industry, with a focus on digital transformation and managed service providers (“MSPs”). Mr. Elfanbaum has joined NMS’ Operating Executive Council (“OEC”), which is comprised of experienced industry leaders […]

Read More »

NMS Capital Portfolio Company Flourish Research Announces Partnership with ENCORE™ Research Group

New York, NY, June 25, 2024 – NMS Capital (“NMS”) portfolio company Flourish Research (“Flourish”) announced today that it has partnered with ENCORE™ Research Group (“ENCORE” or the “Company”). ENCORE™ is a leading clinical research organization with eight locations across Northern Florida. With 100+ investigators, ENCORE™ brings expertise across multiple therapeutic areas including cardiology, metabolic, […]

Read More »

NMS Capital Portfolio Company VONA Case Management Announces Partnership with SkyView CCM Rehabilitation Consulting

New York, NY – June 25, 2024 – NMS Capital (“NMS”) portfolio company VONA Case Management (“VONA”) announced today that it has partnered with SkyView CCM Rehabilitation Consulting (“SkyView” or the “Company”) in a recapitalization of the Company. Terms of the transaction were not disclosed. Founded in 2015 and headquartered in Kalamazoo, Michigan, SkyView is […]

Read More »

Strive Medical Announces Acquisition of the ProMed DME, LLC

Irving, TX, June 2024 – Strive Medical (“Strive” or the “Company”), a portfolio company of NMS Capital (“NMS”), announced today the acquisition of ProMed DME, LLC (“ProMed DME” or the “Company”), a durable medical equipment (“DME”) provider specializing in diabetic continuous glucose monitoring (CGM) supplies. “This transaction is a crucial milestone in Strive Medical’s dedication […]

Read More »
2024 |

DirectMed Imaging Acquires Titanium Medical Imaging

With The Acquisition Of Titanium Medical Imaging, DirectMed Imaging Will Now Provide Expanded Access To Critical Inventory For All Original Equipment Manufacturers San Diego, CA, March 12, 2024 – DirectMed Imaging, the premier supplier of aftermarket medical imaging parts, systems, and training, today announces the acquisition of Houston-based Titanium Medical Imaging, a company with vast expertise […]

Read More »

NMS Capital Portfolio Company U.S. Urology Partners Announces Partnership with Greater Boston Urology, Broadening U.S. Urology Partners’ Network to Include Over 190 Providers Operating Throughout Over 60 Clinical Locations in Five States

New York, NY, December 5, 2023 – NMS Capital (“NMS”) portfolio company U.S. Urology Partners (“U.S. Urology” or the “Company”) is pleased to announce that Greater Boston Urology (“GBU”) has joined its national network of affiliate urology practices. U.S. Urology’s network now encompasses over 190 providers operating throughout over 60 clinical locations in five states. […]

Read More »

NMS Capital Portfolio Company Flourish Research Announces Partnership with Merritt Island Medical Research, Further Expanding Presence in Neuroscience

New York, NY, November 14, 2023 – NMS Capital (“NMS”) portfolio company Flourish Research (“Flourish”) announced today that it has partnered with Merritt Island Medical Research (“MIMR” or the “Company”). MIMR is a leading clinical research site located in Merritt Island, Florida that specializes in neuroscience related indications including Alzheimer’s Disease. The partnership represents the […]

Read More »
2023 |

Health & Wellness Partners, an NMS Capital Portfolio Company Announces Partnership with Hybrid Healthcare Communications

New York, NY, October 9, 2023 – Health & Wellness Partners Group, LLC (“HWP”), a portfolio company of NMS Capital (“NMS”), announced today that it has acquired Hybrid Healthcare Communications, LLC (“Hybrid”). Terms of the transaction were not disclosed. Founded in 2006 and based in Eatontown, NJ, Hybrid brings medical content to life with customized, […]

Read More »

NMS Capital Portfolio Company Flourish Research Announces Partnership with Valley Clinical Trials Marking the Ninth Acquisition Since the Formation of Flourish in 2021

New York, NY, September 15, 2023 – NMS Capital (“NMS”) portfolio company Flourish Research (“Flourish”) is pleased to announce the acquisition of Valley Clinical Trials (“Valley” or the “Company”). Valley is a leading clinical research site with three locations in California that specialize in cardiology, metabolic, and related therapeutic areas. The partnership represents the ninth acquisition since […]

Read More »
About us

NMS Capital is a private investment firm specializing in strategic equity investments of leading middle market companies with an emphasis on sustainable growth trends in both the business services and healthcare services industries.

More About Us
Our Portfolio

We partner with founders and management teams to help accelerate growth and build a wide range of leading companies across the business services and healthcare services sectors.

Our Portfolio